---
document_datetime: 2023-09-21 18:11:19
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/clopidogrel-bms-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: clopidogrel-bms-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.0074454
conversion_datetime: 2025-12-18 21:51:55.272363
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
<!-- image -->

| No      | Scope                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Opinion issued on   | Commission Decision Issued/ amended on   | Product Information affected 2   | Summary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0008 | product Update of Summary of Product Characteristics, Labelling and Package Leaflet Update of SPC sections 4.2 \"Posology and method of administration\", 4.4 \"Special warnings and precautions for use\", 4.5 \"Interaction with other medicinal products and other forms of interaction\", 5.1 \"Pharmacodynamic properties\" and 5.2 \"Pharmacokinetic properties\" to include information on the clopidogrel metabolism pathway, the role of CYP2C19 genetic polymorphism on clopidogrel variability of response, and the potential interaction between clopidogrel and CYP2C19 inhibitors including some proton pump inhibitors, further to the CHMP recommendations taken during the April and May 2009 CHMP meetings. The pharmaceutical form and contents section in the Labelling has also been updated. | 23/07/2009          | 13/08/2009                               | no SPC, Labelling, PL            | longer In March 2009 a publication from JAMA reporting on a large epidemiological study that claimed patients treated simultaneously with clopidrogel and Proton Pump Inhibitors PPI had worse cardiovascular outcomes than those not exposed to PPI was discussed by the PhVWP and CHMP. The CHMP reviewed the evidence pertaining to the drug-drug interaction between clopidrogel and PPIs and analysed this evidence, critical in terms of its methodological and clinical value. Following CHMP recommendations, , the MAHsubmit a variation to update the sections 4.2, 4.4, 4.5, 5.1 and 5.2 of the SPC (and the corresponding sections of the Package Leaflet) to include available information on this topic. The pharmaceutical form and contents section in the Labelling has also been updated. |
| II/0003 | Change(s) to shelf-life or storage conditions The Marketing Authorisation Holder applied to change the storage conditions of the 75 mg film-coated tablets packed in the PVC/PVDC/Alu blisters from \"No special                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 18/12/2008          | 13/02/2009                               | SPC, Labelling, PL               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

Medicinal product no longer authorised 1/2 © European Medicines Agency, 2009. Reproduction is authorised provided the source is acknowledged. Clopidogrel BMS Procedural steps taken and scientific information after the authorisation MAJOR CHANGES 1 1 Major changes e.g. Type II variations, Annex II applications, Renewals and Annual Reassessments 2 SPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet)

<div style=\"page-break-after: always\"></div>

| No   | Scope                                      | Opinion issued on   | Commission Decision Issued/ amended on   | Product Information affected 2   | Summary   |
|------|--------------------------------------------|---------------------|------------------------------------------|----------------------------------|-----------|
|      | storage conditions\" to \"Store below 30°C\". |                     |                                          |                                  |           |

| No      | Scope                                                                                                                                                                                          | Product Information affected 2   | Date 4     |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------|------------|
| IB/0017 | 12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec. 13_b_Change in test proc. for active substance - other changes (replacement/addition)        |                                  | 10/11/2009 |
| IB/0015 | longer 12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec. 13_b_Change in test proc. for active substance - other changes (replacement/addition) |                                  | 10/11/2009 |
| IB/0016 | 13_b_Change in test proc. for active substance - other changes (replacement/addition)                                                                                                          |                                  | 06/11/2009 |
| N/0012  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                               | PL                               | 26/10/2009 |
| IA/0013 | no 12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec.                                                                                           |                                  | 21/10/2009 |
| IB/0011 | 10_Minor change in the manufacturing process of the active substance                                                                                                                           |                                  | 11/08/2009 |
| IB/0010 | 10_Minor change in the manufacturing process of the active substance                                                                                                                           |                                  | 10/08/2009 |
| IB/0009 | 10_Minor change in the manufacturing process of the active substance                                                                                                                           |                                  | 10/08/2009 |
| IB/0007 | 14_a_Change in manuf. of active substance without Ph. Eur. certificate - change in manuf. site                                                                                                 |                                  | 22/01/2009 |
| IB/0006 | 41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                                                                                          | SPC, Labelling, PL               | 30/10/2008 |
| IB/0005 | product 41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                                                                                  | SPC, Labelling, PL               | 30/10/2008 |
| IB/0004 | 42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                                        | SPC                              | 30/10/2008 |
| IB/0002 | 10_Minor change in the manufacturing process of the active substance                                                                                                                           |                                  | 11/08/2008 |
| IB/0001 | 10_Minor change in the manufacturing process of the active substance                                                                                                                           |                                  | 11/08/2008 |

Medicinal product no longer authorised 2/2 MINOR CHANGES 3 3 Minor changes e.g. Type I variations and Notifications 4 Date of entry into force of the change